help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Britt, K. L.
Right arrow Articles by Findlay, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Britt, K. L.
Right arrow Articles by Findlay, J. K.
Endocrinology Vol. 141, No. 7 2614-2623
Copyright © 2000 by The Endocrine Society


ARTICLES

An Age-Related Ovarian Phenotype in Mice with Targeted Disruption of the Cyp 19 (Aromatase) Gene1

Kara L. Britt, Ann E. Drummond, Victoria A. Cox, Mitzilee Dyson, Nigel G. Wreford, Margaret E. E. Jones, Evan R. Simpson and Jock K. Findlay

Prince Henry’s Institute of Medical Research and Department of Anatomy, Monash University (N.G.W.), Clayton, Victoria 3168, Australia

Address all correspondence and requests for reprints to: Prof. J. K. Findlay, Prince Henry’s Institute of Medical Research, P.O. Box 5152, Clayton, Victoria 3168, Australia. E-mail: jock.findlay{at}med.monash.edu.au


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
With the development of a mouse model of estrogen insufficiency due to targeted disruption of the aromatase gene [the aromatase knockout (ArKO) mouse], a new opportunity exists to examine the role of estrogen in ovarian follicular development. Ovaries and serum were collected from wild-type, heterozygous, and ArKO mice at 10–12 and 21–23 weeks and 1 yr of age. The ovaries were assessed histologically and stereologically, with primary, secondary, and antral follicles and corpora lutea counted. The uteri were hypoestrogenic, and serum levels of LH and FSH in ArKO females were elevated above those in heterozygote and wild-type animals at all ages studied. Although estrogen was not a prerequisite for reinitiation of follicle growth, there was a block of follicular development, and no corpora lutea were present in ArKO ovaries. Thus, the ArKO mouse was infertile as a consequence of disrupted folliculogenesis and a failure to ovulate. Hemorrhagic cystic follicles were present by 21–23 weeks of age. The ovarian phenotype degenerated with age, such that by 1 yr there were no secondary or antral follicles, and the primary follicles present were atretic. Extensive interstitial tissue remodeling occurred, exemplified by an influx of macrophages and collagen deposition, coincident with the loss of follicles. In conclusion, the ovarian environment in ArKO mice does not allow the characteristic development of follicles that culminates in ovulation and demonstrates an in vivo requirement of estrogen for normal ovarian function in the mouse.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
THERE IS EVIDENCE supporting a local role for estrogen in the development of follicles in the mammalian ovary (1). Estrogens stimulate the proliferation of granulosa cells and facilitate the differentiating actions of FSH and LH on granulosa cells (2, 3). These autocrine actions of 17ß-estradiol (E2), the principal bioactive estrogen, are mediated via two nuclear transcription factors, estrogen receptor (ER) {alpha} and ß, both of which are present in granulosa cells of mice and rats (4, 5).

A requirement of folliculogenesis for E2 has been implied in earlier studies (reviewed in Refs. 2, 6) and more recently in murine models with targeted disruption of the genes for either ER{alpha} (ERKO) or ERß (ßERKO) (7, 8). However, neither of these models is completely free of the capacity to transduce the E2 signal, given that the alternative ER subtype remains. These models allow neither definition of the critical period of nor of the absolute requirement for E2 action during folliculogenesis.

The recent development of a mouse model lacking the capacity to produce estrogen due to targeted disruption of the Cyp 19 (aromatase) gene (9) provides an opportunity to define the role of E2 in ovarian function. The phenotype of the aromatase knockout (ArKO) female mouse at 12–14 weeks of age was described in a preliminary study (9) as infertile, with ovaries lacking corpora lutea (CL).

The present studies report on the ovarian phenotype of wild-type, heterozygous, and ArKO mice at 10–12 and 21–23 weeks and 1 yr of age. The aim was to determine the impact of aromatase deficiency on the ovarian morphology and the number of follicles that grow to the primary, secondary, and antral stages of development. In addition, the gonadotropin levels within which the ovarian phenotypes are expressed were investigated.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mice
ArKO mice from the Dallas colony (9) were bred in Melbourne, Australia, and genotypically analyzed using a PCR-based strategy to identify exon 9 and the neo insert in the Cyp 19 gene. The mice were kept on a 12-h dark, 12-h light regimen and were fed mouse chow ad libitum. Homozygous mutant males, which are fertile when young, were bred with heterozygous females to produce progeny displaying the expected Mendelian inheritance ratios, with no gender bias observed. No significant differences in litter sizes were observed using wild-type and heterozygous animals. The breeding regimen that was followed did not produce any wild-type animals for this study, and thus, wild-type C57B6 and J129 mice were used as controls (ArKO mice were bred on a J129/C57B6 background) (9). Mean body weight increased significantly with age within each genotype. There were no significant effects of genotype on the mean body weight for any of the ages studied. The animal experimentation and ethics committee of Monash Medical Center approved all experiments.

Sample collections
Vaginal smears were performed daily in the mice. ArKO mice do not exhibit an estrous phase, but display vaginal smears reminiscent morphologically of diestrus and proestrus, alternating between these phases but without any regular cyclicity. Animals in groups of three or four were killed at a stage of the estrous cycle other than estrus for controls and heterozygotes or at random for the ArKO females. Blood was obtained by cardiac puncture and was allowed to clot; serum was separated and stored at -20 C for gonadotropin RIA. Uterine weight was recorded as an index of estrogenicity. One ovary from each animal was frozen in OCT compound (Tissue-Tek, Miles, Elkhart, IN), and stored at -80 C. The other ovary was fixed in formalin and embedded in paraffin blocks, which were serially sectioned at 7 µm. Every fourth section was stained using a modified Masson’s Trichrome (10) technique, dehydrated in ethanol, and coverslipped using DPX (BDH Laboratory Supplies, Poole, UK). Masson’s Trichrome stains collagen fibers blue; cytoplasm red, and nuclei blue-black.

Morphological classification of growing follicles
Follicle types in ovarian cross-sections were defined as follows. Primary follicles comprised an oocyte surrounded by a single layer of cuboidal granulosa cells. Secondary follicles comprised an oocyte surrounded by two or more layers of granulosa cells with no antrum. Antral follicles were distinguished by an antrum within the granulosa cell layers enclosing the oocyte. An extensive analysis of primordial follicles in ArKO ovaries is currently underway, and thus, primordial follicle data will not be reported here. Follicles were determined to be atretic if they displayed two or more of the following criteria within a single cross-section: more than two pyknotic nuclei, granulosa cells within the antral cavity, granulosa cells pulling away from the basement membrane, and/or uneven layers of granulosa cells.

Stereological analysis
Stereological assessment of numbers of growing follicles (primary, secondary, and antral) was performed using a modification of the contemporary fractionator method (11). This approach involves counting all oocyte nuclei in a known fraction of the ovary. The total number of oocytes per ovary, and therefore follicle number, was then estimated by multiplying the number counted by the inverse of the sampling fractions. In this instance, every fourth section was mounted for stereological examination. Sections were sampled using a systematic uniform random sampling scheme (12) generated by a computer-driven stage (Multicontrol 2000, ITK, Lahnau, Germany) mounted on an Olympus Corp. BX50 microscope (Albertslund, Denmark). The microscope image was captured using a Pulinex TMC-6 (Sunnyvale, CA) video camera and interfaced to the counting frames that were generated using CASTGRID (version 1.10) software, supplied by Olympus Corp. In brief, the boundary of the sections was mapped at medium power (x20). The software was then used to select fields for counting starting in the upper lefthand corner of the section and advancing by 300 µm in the X direction until the section was no longer seen. The stage was then moved 300 µm in the Y direction, and the process was repeated until the whole section was sampled. A sampling frame consisting of two inclusion and two exclusion boundaries, as defined by Gundersen (13), was used. Some nuclei gave rise to profiles in adjacent sections, resulting in an overestimate of the number of oocytes, which was corrected using Abercrombie’s method (14) with the addition of the lost cap correction described by Floderus (15). Both nuclear and follicle diameters associated with counted oocyte nuclei were measured. Profiles of oocyte nuclei and follicles were close to circular. Slight deviations from the circular were accommodated by calculating the geometric mean of the short and long axes. The mean diameter of nuclei used for the purposes of the Abercrombie correction was the mean of the upper 30% of the diameters measured.

Numbers of CL
An estimate of the total number of CL per ovary was made using a physical dissector approach (16). As CLs had a diameter greater than 175 µm, every 25th section was projected onto paper, and all CLs were traced. Traces were then compared to determine the total number of CLs per ovary.

Terminal deoxynucleotidyltransferase-mediated deoxy-UTP nick end labeling (TUNEL) assay
Reagents supplied by Roche Molecular Biochemicals (Mannheim, Germany) were used for TUNEL staining. Selected formalin-fixed paraffin sections cut at 7 µm were dewaxed in histolene, rehydrated with ethanol, and washed in 0.01 M PBS. Proteinase K (15 µg/ml) was applied to the sections for 15 min at 37 C, followed by washing in PBS. At this point one section per group was subjected to deoxyribonuclease treatment (0.375 U/µl) for 15 min at 37 C (positive control). A cocktail of dioxygenin-DNA labeling mix, terminal transferase, and cobalt chloride, prepared in 1 x terminal transferase buffer was applied to the slides and incubated at 37 C for 1 h. After washing the slides in PBS, the slides were blocked in buffer 2 (blocking reagent dissolved in 0.1 M maleic acid and 0.15 M NaCl) for 30 min before the addition of an alkaline phosphatase-conjugated sheep antidioxygenin (1:2000), to the sections. After a 1-h incubation at room temperature, the antibody was washed off with three changes of PBS, each for 10 min. An enzyme-catalyzed color reaction with nitro blue tetrazolium chloride (337.5 µg/ml), x-phosphate/5-bromo-4-chloro-3-indolyl-phosphate (175 µg/ml), and 0.72 mg/ml levamisole (a blocker of endogenous alkaline phosphatase) produced an insoluble precipitate visualizing hybrid molecules in the apoptotic cells. The color reaction was left to develop in the dark for 30 min, at which time it was stopped by washing the sections with distilled water. After a 30-min incubation in 95% ethanol, sections were dehydrated in 100% ethanol (twice, 3 min each time) and cleared in Histosol (twice, 3 min each time) before being coverslipped with DPX.

Gonadotropin assays
LH and FSH were measured in specific RIAs using reagents supplied by the NIADDK (LH antiserum S-10, FSH antiserum S-11) with rat standards (rLH RP-2, rFSH RP-2) and tracer. All samples for each hormone were measured in a single assay, with intraassay coefficients of variation of 6.5% and 6.9% for FSH and LH, respectively. The sensitivities of the assays were 1.15 ng/ml and 96 pg/ml for FSH and LH, respectively (at the 90% effective dose).

Nonspecific esterase histochemistry
To establish whether cells infiltrating the ovary were macrophages, the sections were stained for nonspecific esterase, an enzyme prevalent in monocytes and macrophages (17). Representative sections from three or four ovaries of ArKO and wild-type animals at 10–12 weeks and 1 yr were selected for esterase staining. Frozen sections were fixed for 30 min in 4% paraformaldehyde, followed by two washes in 0.15 M Na2HPO4 buffer (pH 7.5). Immediately before use, 1 ml 4% NaNO2 was added to 1 ml 4% pararosaniline HCl, and 1.6 ml of this mixture were then combined with 0.5 ml 1% napthyl acetate and 20 ml 0.15 M Na2HPO4 buffer (pH 7.5) and mixed thoroughly. The solution was added dropwise to the sections and incubated for 20–30 min at room temperature. The slides were then washed in three changes of distilled water, dehydrated in ethanol, and coverslipped with DPX.

Statistical analyses
Data are presented as the mean ± SEM. Statistical analysis was performed using SigmaStat statistical software (version 2.0, Jandel Corp., San Rafael, CA). Longitudinal comparisons of data at 10–12 weeks, 21–23 weeks, and 1 yr of age and comparisons within each age group across genotypes were performed using an ANOVA in conjunction with a Tukey test. In some cases it was necessary to normalize the data by log transformation before analysis. If normality or equal variance failed, a Kruskal-Wallis test in conjunction with Dunn’s multiple comparisons test was performed.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Uterine weight
Mean uterine weights increased significantly with age in the wild-type and heterozygous groups, but not in the ArKO group (Table 1Go). By 1 yr of age, the uterine weights of the ArKO mice were only 30% of those recorded for wild-type and heterozygous groups, both of which were similar.


View this table:
[in this window]
[in a new window]
 
Table 1. Uterine weight (milligrams) as a function of age and genotype1

 
Serum concentrations of gonadotropins
The levels of serum FSH were significantly higher in ArKO mice than in wild-type and heterozygous mice at each of the ages studied (Fig. 1Go). At 10–12 weeks of age, the heterozygotes exhibited significantly higher levels of FSH than the wild-type animals, although by 21–23 weeks of age, the heterozygotes had FSH levels similar to those of the wild-type animals. By 1 yr of age, the levels of FSH in wild-type animals had increased 2-fold relative to those in 10- to 12-week wild-type animals. FSH levels in the ArKO mice were 3-fold higher than levels measured in the serum collected from 1-yr-old wild-type mice. Interestingly, FSH levels in heterozygotes were only 50% of wild-type levels at 1 yr (Fig. 1Go).



View larger version (20K):
[in this window]
[in a new window]
 
Figure 1. Serum levels of LH and FSH collected from wild-type, ArKO, and heterozygous mice, at 10–12 and 21–23 weeks and 1 yr of age (mean ± SEM). Different letters denote statistical significance: a, b, and c operate within an age group across genotypes, and x and y operate within a genotype across age groups. P < 0.05 vs. the appropriate control. The number of animals per group is indicated directly below the histogram. All mice were in a stage of the cycle other than estrus.

 
The serum LH levels also increased significantly in ArKO mice compared with wild-type age-matched controls. At 10–12 weeks of age, heterozygous mice had significantly higher levels of serum LH than their wild-type counterparts (Fig. 1Go). At 21–23 weeks of age, LH levels in heterozygous and wild-type animals were similar. By 1 yr of age, LH levels in ArKO mice were approximately 3-fold higher than those in the serum of wild-type and heterozygous mice (Fig. 1Go).

Morphological description of ovaries
Wild-type ovaries at all ages studied contained follicles at all stages of development and CL (Fig. 2Go, A and B, and Table 2Go). At 21–23 weeks and 1 yr of age, some antral follicles of wild-type ovaries showed disruption of the cellular layers and the presence of pyknotic nuclei, typical of apoptotic granulosa cells. Healthy follicles were found adjacent to atretic follicles. The cellular architecture of the ovary, particularly that of the interstitial region, was well defined and compact, as shown in the example at 10–12 weeks of age (Figs. 2Go, A and B, and 4F).



View larger version (172K):
[in this window]
[in a new window]
 
Figure 2. Histological representation of wild-type and heterozygous ovarian phenotypes at 10–12 weeks of age. Ovaries were collected while the mice were in diestrus. A, Wild-type 10- to 12-week-old ovary. Follicles (F) at all stages of maturation and CL were present (magnification, x40). B, High magnification view of the inset in A, showing primary follicles (PF) and follicles (F) at later stages of maturation as well as CL (magnification, x100). C, Heterozygous ovary, 10–12 weeks of age. Follicles of all stages of maturation, including primary follicles (PF), and CLs were present. Note the presence of open oval structures (arrow; magnification, x40). D, High magnification view of the inset in C. Note the open oval structures (OO) present in the interstitium containing granulosa cell-like cells (arrows) around the periphery (magnification, x100).

 

View this table:
[in this window]
[in a new window]
 
Table 2. Numbers of corpora lutea per ovary in wild-type, heterozygote, and ArKO mouse ovaries

 
Heterozygous ovaries at all ages studied contained follicles at all stages of development and CL. Figure 2CGo shows a representative section of a 10- to 12-week-old heterozygous ovary. Open oval structures, postulated to be the remains of early stage follicles, were present within the interstitial region of the heterozygous ovaries (Figs. 2Go, C and D, and 4I). These structures in most cases possessed a layer of squamous and/or cuboidal granulosa cell-like cells around the periphery (Figs. 2DGo and 4IGo). Pyknotic nuclei and cellular debris were present in the antra of some large follicles, particularly at 1 yr (data not shown).



View larger version (118K):
[in this window]
[in a new window]
 
Figure 4. A, Large hemorhagic cyst (Cy) present in ArKO ovary at 1 yr of age. Note also the increased collagen (C) content of this ovary, as indicated by the intense blue staining (magnification, x40). B, Atretic (determined histologically) degenerative follicles (DF) of antral size in 1-yr-old ArKO ovary (magnification, x100). C, TUNEL staining of the section consecutive to B, showing the same follicles (magnification, x100). Note the TUNEL-positive cells (stained dark blue and indicated with arrows). D, Macrophage-like cells (m{phi}) localized in the Masson’s Trichrome-stained 1-yr-old ArKO ovary (magnification, x100). E, Nonspecific esterase staining of 1-yr-old ArKO ovaries (magnification, x100), showing esterase-positive cells (e+), as depicted by brown-red granular staining. F, Interstitial region of the 10- to 12-week-old wild-type ovary, with a CL and interstitial cells (magnification, x200). G, Interstitial region of 10- to 12-week-old ArKO ovary. Open oval structures (OO) and collagen deposits (CD) were observed (magnification, x100). H, Interstitial region of 1-yr-old ArKO (magnification, x200). Note the blue appearance of the ovary, representing an increased collagen deposition (C). I, Open oval structures (OO) found in 10- to 12-week-old heterozygous ovary (magnification, x200).

 
An age-dependent phenotype was observed in the ArKO ovaries. At 10–12 weeks of age, the ovary contained follicles of all types (primordial, primary secondary, and antral), but no CL (Fig. 3AGo and Table 2Go). Many of the antral follicles in these sections were histologically abnormal. Disrupted, nonuniform layers of granulosa cells and numerous pyknotic nuclei, suggestive of atretic follicles, were present in most sections. Apoptosis was detected most notably in the granulosa cells of larger, antral size follicles. By 21–23 weeks of age the phenotype in the ArKO ovary was more pronounced. Although follicles at all stages were still observed (Fig. 3CGo), the typical appearance of closely packed growing follicles observed in wild-type and heterozygous ovaries (Fig. 2Go, A–D) was lost, and many of the follicles present were atretic. Preantral follicles were randomly scattered throughout the ovary, and many of the antral follicles that were present were cystic and hemorrhagic (Fig. 3Go, C and D). The ovaries of 1-yr-old ArKO mice differed vastly in appearance from the ovaries of age-matched controls. There were no identifiable secondary or antral follicles in these ovaries (Fig. 4Go, E and F), although structures that may represent remnants of large follicles were present (Fig. 3EGo), many of which were cystic and hemorrhagic (Figs. 3Go, E and F, and 4A). In some cases the cysts constituted the majority of the ovarian space (Fig. 4AGo). Studies are underway to characterize these degenerative follicular structures. The primary follicles present were abnormal, consisting of oddly shaped granulosa cells, many of which were pyknotic. Granulosa cell apoptosis, as determined by TUNEL assay, was widespread throughout the ovary (Fig. 4Go, B and C).



View larger version (144K):
[in this window]
[in a new window]
 
Figure 3. Histological representation of ArKO ovaries at 10–12, 21–23, and 1 yr of age. A, Ten- to 12-week-old ArKO ovary. Follicles (F) at all stages of development are present, but are unhealthy in appearance. Hemorrhagic cysts (Cy) are present in secondary and antral sized follicles (magnification, x40). B, High magnification view of A. Blood-filled follicular cyst (Cy) adjacent to follicles (F) with a healthy appearance. Collagen deposits (CD) are present (magnification, x100). C, Twenty-one- to 23-week-old ArkO ovaries. Follicles up to the antral stage are present as well as the open oval structures (arrows) observed in heterozygous ovaries. Note the presence of hemorrhagic cysts (Cy), commonly toward the periphery of the ovary (magnification, x40). D, High magnification view of C. Shown is an antral sized follicle adjacent to a hemorrhagic cyst (Cy). Also shown with arrows are open oval structures in these ovaries (magnification, x100). E, One-year-old ArKO showing most notably the absence of normal secondary or antral follicles and a dramatic increase in collagen deposition. Degenerated follicles (DF) and cysts are also present (magnification, x40). F, High magnification view of E showing blood-filled cysts within the follicular space and the presence of macrophages (m{phi}) at this site of degeneration (magnification, x100).

 
In contrast to those of wild-type animals (Fig. 4FGo), the interstitial regions of the ArKO mouse ovary were disorganized in appearance, with less densely packed interstitial cells (Fig. 4Go, G and H). There was also an increased deposition of collagen with age [scattered collagen deposits in 10- to 12-week-old animals (Figs. 3Go, A and B, and 4H) compared with substantial collagen deposition in 1-yr-old mice (Figs. 3Go, E and F, and 4 H]. As shown in Fig. 4Go, H and I, both heterozygote and young ArKO mice had open oval structures in the interstitial regions.

Cells hypothesized to be macrophages in the ArKO ovary (Fig. 4DGo) were identified using a nonspecific esterase stain (Fig. 4EGo). In ArKO ovaries, the numbers of esterase-positive cells increased with age. The macrophages were generally localized to sites of hemorrhagic cysts or areas of advanced degeneration within the interstitial region (Figs. 3FGo and 4DGo).

Numbers of follicles
As expected, primary follicle numbers were always in excess of secondary and antral follicle numbers regardless of age or genotype (Fig. 5Go). There were no significant effects of age on the number of follicles in each class in the wild-type group. ArKO ovaries contained significantly more primary follicles than wild-type ovaries at 21–23 weeks and more than heterozygous ovaries at 10–12 and 21–23 weeks (Fig. 5Go). At 10–12 weeks there were significantly fewer secondary follicles in the ArKO ovaries, and by 1 yr of age, no identifiable secondary or antral follicles were present in the ovaries. Ovaries of heterozygotes contained fewer primary follicles relative to wild-type and ArKO ovaries at all ages studied, although significance was only obtained at 21–23 weeks (Fig. 5Go). The secondary and antral follicle numbers of heterozygotes were consistent with those of the other genotypes.



View larger version (19K):
[in this window]
[in a new window]
 
Figure 5. Effects of genotype and age on ovarian follicle numbers (n = 3–4 ovaries/group, except for the 1-yr-old wild-type antral follicle group, where only two of the three ovaries counted contained antral follicles). *, No follicles of this type were present in the ovary. Different letters denote statistical significance: x, y, and z operate within an age group across the genotypes, and a and b operate within a genotype between age groups. P < 0.05–0.001 vs. the appropriate control.

 
Oocyte nuclear diameter
In general, oocyte nuclear diameter increased with follicular development (Fig. 6Go). The nuclear diameters of oocytes within primary follicles of heterozygous ovaries at 21–23 weeks were greater than those in the corresponding wild-type follicles. Also at 21–23 weeks, nuclear diameters of oocytes within secondary and antral follicles of heterozygotes were greater than those in the corresponding ArKO mice.



View larger version (20K):
[in this window]
[in a new window]
 
Figure 6. Effects of genotype and age on oocyte nuclear diameter (n = 3–4 ovaries/group, except for the 1-yr-old wild-type antral follicle group, where only two of the three ovaries counted contained antral follicles). *, No follicles of this type were present in the ovary. Different letters denote statistical significance: x and y operate within an age group across the genotypes, and a and b operate within a genotype between age groups. P < 0.05–0.005 vs. the appropriate control.

 
Follicle diameter
The only significant differences noted were in primary follicles. The mean diameter of primary follicles in ovaries of 10- to 12-week-old wild-type mice was significantly larger than the diameters of primary follicles at 21–23 weeks or 1 yr of age (Fig. 7Go). The mean diameter of primary follicles in ovaries of 10- to 12-week-old ArKO mice was significantly reduced relative to that of wild-type primary follicles at this age. Primary follicles of 21- to 23-week-old heterozygous ovaries had a diameter significantly larger than those of the comparable wild-type and ArKO follicles.



View larger version (23K):
[in this window]
[in a new window]
 
Figure 7. Effects of genotype and age on ovarian follicle diameter (n = 3–4 ovaries/group, except for the 1-yr-old wild-type antral follicle group, where only two of the three ovaries counted contained antral follicles). *, No follicles of this type were present in the ovary. Means with different letters denote statistical significance. Within an age group across the genotypes, x and y denote statistical significance; within a genotype, a and b denote significant differences between age groups. P < 0.001 vs. the appropriate control.

 
Number of CL
ArKO ovaries at all ages studied were devoid of CL. The numbers of CL for wild-type and heterozygous ovaries at each age were not statistically different (Table 2Go).


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Female mice at 10–12 and 21–23 weeks and 1 yr of age with targeted disruption of the Cyp 19 gene have disrupted folliculogenesis and lack CL. The hypoestrogenic state of 10- to 12-week-old female ArKO mice was characterized by infantile uteri and elevated circulating levels of gonadotropins, confirming the original observations of Fisher et al. (9). We now report that with increasing age, ovarian antral follicles become hemorrhagic and cystic, coincident with an infiltration of macrophages and increased deposition of collagen to the interstitial regions. By 1 yr of age there were no identifiable secondary or antral follicles present in the ArKO ovaries, and apoptotic cells, indicative of atresia, were prevalent in the remaining primary follicles. Furthermore, elevated gonadotropin levels and infantile uteri remained characteristic phenotypes of older ArKO females. High levels of LH and androgen are known to bring about widespread atresia (18, 19), and the LH surge is associated with an infiltration of macrophages at the time of ovulation in rodents (20). These data show that estrogen is not obligatory for the commitment of primordial follicles to growth, but is required, either directly or indirectly, for the full development of antral follicles and subsequent steps in folliculogenesis leading to ovulation.

Although the ovaries of ArKO mice lack the capacity to produce E2, and the animals exhibit a phenotype consistent with hypoestrogenicity (Ref. 9 and this study), there are two other sources of estrogenic activity that could impact on the model. The ovaries of maternal heterozygotes are a source of estrogen, which could cross the placenta during pregnancy and influence the development of the fetal ArKO ovary. It is possible that the effects of maternally derived E2 on the fetal ovary in utero could still be operative on follicles in the immediate postnatal period. The extent to which these effects of E2 are important for normal postnatal folliculogenesis is unknown. However, by 10–12 weeks of age, E2 from this source is unlikely to play a role in folliculogenesis, given the rapid half-life of E2 and the absence of {alpha}-fetoprotein, an E2 carrier in rodents (21). We conclude that even if maternal estrogen plays a role in stimulating ovarian differentiation and primordial follicle organization, follicular development from the point of primordial follicle activation up to the antral follicle stage can occur in the absence of estrogen. A second source of estrogenic activity arises from the phytoestrogens present in mouse chow (10% soy). Preliminary data (ovarian and uterine weights) from ArKO mice raised and maintained on a soy-free diet indicate that these mice exhibit the same, but a more exacerbated, hypoestrogenic phenotype relative to those ArKO mice raised and maintained on the soy-containing diet (22). The data suggest that the onset of the ovarian phenotype was accelerated in ArKO mice fed soy-free chow.

The data from this study support the conclusion that E2 is required directly or indirectly for normal growth of committed follicles in the mouse. It is not clear as yet whether estrogen is important in determining the size of the primordial follicle pool. Studies in the ArKO mouse are currently in progress to establish the impact of estrogen, if any, at this step in folliculogenesis. The lack of CL and the presence of many large unhealthy antral follicles at 10–12 weeks of age in the ArKO ovaries pinpoint a role for E2 in the progression of follicles from the secondary to the tertiary stage at around the time of selection. At this time proliferation of granulosa cells is maximal, and there is up-regulation of expression of genes in granulosa cells, many of which are regulated by E2 and FSH (2). For example, it has been shown recently that cyclin D2, a critical component of the cell cycle machinery in granulosa cells, is influenced independently by both FSH and E2 (3, 23). Furthermore, E2 is known to modulate the up-regulation of expression of LH receptors by FSH (2, 24). The follicular status of ovaries of ArKO mice suggests a role for E2 in vivo in the growth and differentiation of granulosa cells in secondary follicles under the influence of FSH.

The effect of age on the phenotype of the ArKO ovaries was pronounced. Cystic and hemorrhagic follicles were prevalent in the ovaries of older animals, and the primary follicles that remained were atretic. If there is no change in the exit rate from the primordial pool and yet there is an absence of secondary and antral follicles at 1 yr of age, this implies that the oocytes of primary follicles die, resulting in the loss of follicles of this type from the ovary. It was interesting to note the distinct ovarian phenotype of the heterozygote mouse. The open oval structures were similar to the open vacuoles present in GnRH antagonist-treated ER{alpha} knockout ({alpha}ERKO) mice (25). We postulate that these structures, present in heterozgous and ArKO mice, are the remains of early stage follicles that have undergone atresia. The reduced numbers of primary follicles in ovaries of heterozygous mice, which are evident within a different gonadotropin milieu, add a new perspective to studies investigating folliculogenesis. The interstitial areas of the ArKO ovaries were characterized by an apparent decrease in the density of stromal cells with a more spreadout/disorganized appearance. This may be due to the collagen deposits in these mice. By 1 yr of age, the interstitial regions of the ArKO ovaries contained substantial collagen deposition, characteristic of tissues that are fibrotic and are undergoing degeneration and tissue remodeling. There was also a massive infiltration of macrophages to the interstitial region and to sites of follicle degeneration. It is not clear whether the phenotype observed is due to the lack of estrogen, to the elevated levels of gonadotropin and testosterone (9), or to both.

The ovarian phenotype in estrogen-deprived ArKO mice has some similarities to other mouse models. Risma et al. (26) provided direct evidence of the effects of chronic exposure to LH on the ovary. They generated transgenic mice overexpressing a LHß transgene in the pituitary; thus, these mice exhibited elevated levels of LH while maintaining normal FSH levels. The ovaries of these transgenic mice contained blood-filled cysts, misshapen granulosa cells, and luteinized cells. The ovaries of these transgenic mice contained 45% fewer primordial follicles at 5 weeks of age, and by 3 months contained decreased numbers of primordial and primary follicles (18), suggesting an increase in primordial follicle cell death. The anovulation observed in these mice was reversed via the administration of a LH-like surge (hCG bolus), suggesting that the anovulation is the result of elevated basal LH levels and the absence of a LH surge (27). Testosterone levels in these mice were 3–5 times higher than those in wild-type animals and may play a significant role in the phenotype observed.

It should be noted that the ovarian morphology of ArKO mice does not resemble that of polycystic ovarian syndrome in humans principally because the thecal layer is not hypertrophied, and there is no pearl drop appearance of follicles. It appears, however, to resemble the ovarian morphology of the ERKO mice, which also had enlarged and hemorrhagic cystic follicles (7). They exhibit elevated LH levels and a termination of follicle development at the antral stage (7). This is consistent with the ArKO model; however, the ovarian phenotype of ERKO mice is apparent at the onset of puberty (20–22 days). No data are available yet for ArKO mice at this age. Additionally, ERKO mice display increased estrogen levels, whereas serum FSH levels are reportedly unaltered (28). The role of estrogen in the pathology observed is complicated by the presence of a second ER, ERß. The generation of an ERß knockout via gene disruption (28, 29) provides evidence for differing roles for the two receptors. Although serum levels of LH and FSH were normal, these mice appeared to be subfertile, with folliculogenesis arrested in some follicles. The ßERKO mouse is dissimilar to the ArKO mouse, in that it remains fertile despite having fewer CLs, which translates into fewer litters with fewer pups (8).

Treatment of ERKO mice with a GnRH antagonist lowered LH levels, returned the ovarian morphology to that comparable with wild-type morphology, and resulted in the absence of cystic follicles (25), demonstrating that the multiple cysts were the result of chronic hyperstimulation by elevated LH. These data are in agreement with those of the LHß transgene overexpression.

Mice lacking both ER{alpha} and ERß expressed an ovarian phenotype distinct from those of the {alpha}ERKO and ßERKO models (30), but at 2.5–7 months of age exhibited some similarities to the ArKO mouse. In the double {alpha}ß knockout female, the ovary contained primordial and growing follicles, some possessing a large antrum, no CL, and elevated serum LH levels, but no hemorrhagic cyst formation. The researchers also reported structures resembling seminiferous tubules in these mice that to date have not been observed in ovaries of ArKO mice. FSHß-deficient mice are infertile and possess small ovaries lacking normal follicles beyond the preantral stage and CL (31). These mice have normal estrogen levels, but elevated LH levels. Interestingly, these mice do not possess follicular cysts. This model demonstrates that FSH is not required for the development of ovarian follicles up to the antral stage. It also suggests a role for elevated LH levels in the pathogenesis of the ovarian phenotype observed in the ArKO, as the phenotype observed at 9–12 weeks in the FSHß knockout mice is similar to that observed in the ArKO mice at the same age.

In conclusion, the ArKO mouse is proving to be a valuable model for investigating the role of estrogen in the folliculogenic process. Dissecting the importance of changes in serum gonadotropins and testosterone, as opposed to a lack of estrogen, in the manifestation of the ArKO ovarian phenotype will be an essential part of future studies.


    Acknowledgments
 
The assistance of Ian Boundy (Department of Anatomy, Monash University) with histological techniques, Sue Hayward (Institute of Reproduction and Development) with the gonadotropin assays, and Claudette Thiedeman and Sue Panckridge with preparation of the manuscript is gratefully acknowledged.


    Footnotes
 
1 This work was supported by the National Health and Medical Research Council of Australia (Regkey 983212), the Victorian Breast Cancer Research Consortium, and grants from the USPHS (R37-AG-0817) and Australian Research Council (09600657). Back

Received November 10, 1999.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Drummond AE, Findlay JK 1999 The role of estrogen in folliculogenesis. Mol Cell Endocrinol 151:57–64[CrossRef][Medline]
  2. Richards JS 1980 Maturation of ovarian follicles: actions and interactions of pituitary and ovarian hormones on follicular cell differentiation. Physiol Rev 60:51–89[Free Full Text]
  3. Robker RL, Richards JS 1998 Hormone-induced proliferation and differentiation of granulosa cells: a coordinated balance of the cell cycle regulators cyclin D2 and p27Kip1. Mol Endocrinol 12:924–940[Abstract/Free Full Text]
  4. Couse JF, Lindzey J, Grandrian K, Gustafsson J-Å, Korach KS 1997 Tissue distribution and quantitative analysis of estrogen receptor-{alpha} (ER{alpha}) and estrogen receptor-ß (ERß) messenger ribonucleic acid in the wildtype and ER{alpha}-knockout mouse. Endocrinology 138:4613–4621[Abstract/Free Full Text]
  5. Drummond AE, Baillie AJ, Findlay JK 1999 Ovarian estrogen receptor {alpha} and ß mRNA expression: impact of development and estrogen. Mol Cell Endocrinol 149:153–161[CrossRef][Medline]
  6. Couse JF, Korach KS 1999 The estrogen receptor null mice: what we have learned and where will they lead us. Endocr Rev 20:358–417[Abstract/Free Full Text]
  7. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O 1993 Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 90:11162–11166[Abstract/Free Full Text]
  8. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafsson J-Å, Smithies O 1998 Generation and reproductive phenotypes of mice lacking estrogen receptor ß. Proc Natl Acad Sci USA 95:15677–15682[Abstract/Free Full Text]
  9. Fisher CR, Graves KH, Parlow AF, Simpson ER 1998 Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci USA 95:6965–6970[Abstract/Free Full Text]
  10. Gurr E 1973 Biological staining methods. 8th ed. Searle Diagnostics, Buckinghamshire, UK, pp 46–47
  11. Gundersen HJG, Bagger P, Bendtsen TF, Evans SM, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard JR, Pakkenberg B, Sorensen FB, Vesterby A, West MJ 1988 The new stereological tools: dissector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96:857–881[Medline]
  12. Gundersen HJG, Jensen EB 1987 The efficiency of systematic sampling in stereology and its prediction. J Microsc 147:229–263[Medline]
  13. Gundersen HJG 1977 Notes on the estimation of the numerical density of arbitrary profiles: the edge effect. J Microsc 111:219–223
  14. Abercrombie M 1946 Estimation of nuclear population from microtome sections. Anat Rec 94:239–247[CrossRef]
  15. Floderus S 1944 Untersuchungen uber den Bau der menschlichen hypophyse mit besonderer Berucksichtigung der quantitativen mikromorphologischen Verhaltnisse. Acta Pathol Microbiol (Scand) 53:1–276
  16. Sterio DC 1984 The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc 134:127–136[Medline]
  17. van Furth R 1988 Phagocytic cells: development and distribution of mononuclear phagocytes in normal steady state and inflammation. In: Gallin JI, Goldstein IM, Snyderman R (eds) Inflammation: Basic Principles and Clinical Correlates. Raven Press, New York, pp 281–295
  18. Flaws JA, Abbud R, Mann RJ, Nilson JH, Hirshfield AN 1997 Chronically elevated luteinizing hormone depletes primordial follicles in the mouse ovary. Biol Reprod 57:1233–1237[Abstract]
  19. Hillier SG 1985 Sex steroid metabolism and follicular development in the ovary. In: Clarke JR (ed) Oxford Reviews of Reproductive Biology. Oxford University Press, London, vol 7:168–222
  20. Norman RJ, Bransstrom M 1994 White cells and the ovary-incidental invaders or essential effectors? J Endocrinol 140:333–336[Abstract/Free Full Text]
  21. Esumi H, Takahashi Y, Seki M, Sato S, Nagase S, Sugimura T 1982 Perinatal changes of {alpha}-fetoprotein concentration in the serum and its synthesis in the liver of analbuminemic rats. Cancer Res 42:306–308[Abstract/Free Full Text]
  22. Britt KL, Drummond AE, Jones MME, Dyson M, Wreford NG, Simpson ER, Findlay JK The effects of targeted disruption of the Cyp 19 (aromatase) gene on folliculogenesis in mice. 30th Annual Conference of the Australian Society for Reproductive Biology, Melbourne, Australia, 1999 (Abstract 86)
  23. Sicinski P, Donaher JL, Geng Y, Parker SB, Gardner H, Park MY, Robker RL, Richards JS, McGinnis LK, Biggers JD, Eppig JJ, Bronson RT, Elledge SJ, Weinberg RA 1996 Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384:470–474[CrossRef][Medline]
  24. Sheela Rani CS, Salhanick AR, Armstrong DT 1981 Follicle stimulating hormone induction of luteinizing hormone receptors in cultured rat granulosa cells: examination of the need for steroids in the induction process. Endocrinology 108:1379–1385[Abstract/Free Full Text]
  25. Couse JF, Bunch DO, Lindzey J, Schomberg DW, Korach KS 1999, Prevention of the polycystic ovarian phenotype and characterisation of ovulatory capacity in the estrogen receptor-{alpha} knockout mouse. Endocrinology 140:5855–5865
  26. Risma K, Clay C, Nett T, Wagner T, Yun J, Nilson J 1995 Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries and ovarian tumours. Proc Natl Acad Sci USA 92:1322–1326[Abstract/Free Full Text]
  27. Mann RJ, Keri RA, Nilson JH 1999 Transgenic mice with chronically elevated luteinizing hormone are infertile due to anovulation, defects in uterine receptivity, and midgestational pregnancy failure. Endocrinology 140:2592–601[Abstract/Free Full Text]
  28. Korach KS 1998 Estrogen receptor knock-out mice: molecular and endocrine phenotypes. Proc Natl Acad Sci USA 93:5925–5930[Abstract/Free Full Text]
  29. Gustafsson JA Physiology and molecular biology of estrogen receptor. Annual Meeting of the Society for the Study of Reproduction, TX, 1998 (Abstract SA-1)
  30. Couse JF, Curtis Hewitt A, Bunch DO, Sar M, Walker VR, Davis BJ, Korach KS 1999 Postnatal sex reversal of the ovaries in mice lacking estrogen receptors {alpha} and ß. Science 286:2328–2331[Abstract/Free Full Text]
  31. Kumar TR, Wang Y, Lu N, Matzuk MM 1997 Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat Genet 15:201–204[CrossRef][Medline]



This article has been cited by other articles:


Home page
Endocr. Rev.Home page
M. A. Edson, A. K. Nagaraja, and M. M. Matzuk
The Mammalian Ovary from Genesis to Revelation
Endocr. Rev., October 1, 2009; 30(6): 624 - 712.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Lee, D.-W. Kang, S. Hudgins-Spivey, A. Krust, E.-Y. Lee, Y. Koo, Y. Cheon, M. C. Gye, P. Chambon, and C. Ko
Theca-Specific Estrogen Receptor-{alpha} Knockout Mice Lose Fertility Prematurely
Endocrinology, August 1, 2009; 150(8): 3855 - 3862.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
T. da Silva Faria, F. de Bittencourt Brasil, F. J B Sampaio, and C. da Fonte Ramos
Maternal malnutrition during lactation alters the folliculogenesis and gonadotropins and estrogen isoforms ovarian receptors in the offspring at puberty
J. Endocrinol., September 1, 2008; 198(3): 625 - 634.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Motola, M. Popliker, and A. Tsafriri
Are Steroids Obligatory Mediators of Luteinizing Hormone/Human Chorionic Gonadotropin-Triggered Resumption of Meiosis in Mammals?
Endocrinology, September 1, 2007; 148(9): 4458 - 4465.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
A. M Dorward, K. L Shultz, and W. G Beamer
LH analog and dietary isoflavones support ovarian granulosa cell tumor development in a spontaneous mouse model
Endocr. Relat. Cancer, June 1, 2007; 14(2): 369 - 379.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. R. Barnett, D. Tomic, R. K. Gupta, K. P. Miller, S. Meachum, T. Paulose, and J. A. Flaws
The Aryl Hydrocarbon Receptor Affects Mouse Ovarian Follicle Growth via Mechanisms Involving Estradiol Regulation and Responsiveness
Biol Reprod, June 1, 2007; 76(6): 1062 - 1070.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
K.R. Barnett, C. Schilling, C.R. Greenfeld, D. Tomic, and J.A. Flaws
Ovarian follicle development and transgenic mouse models
Hum. Reprod. Update, September 1, 2006; 12(5): 537 - 555.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
W. Luo and M. C. Wiltbank
Distinct Regulation by Steroids of Messenger RNAs for FSHR and CYP19A1 in Bovine Granulosa Cells
Biol Reprod, August 1, 2006; 75(2): 217 - 225.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Shiina, T. Matsumoto, T. Sato, K. Igarashi, J. Miyamoto, S. Takemasa, M. Sakari, I. Takada, T. Nakamura, D. Metzger, et al.
From the Cover: Premature ovarian failure in androgen receptor-deficient mice
PNAS, January 3, 2006; 103(1): 224 - 229.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
J. L Juengel, D. A Heath, L. D Quirke, and K. P McNatty
Oestrogen receptor {alpha} and {beta}, androgen receptor and progesterone receptor mRNA and protein localisation within the developing ovary and in small growing follicles of sheep
Reproduction, January 1, 2006; 131(1): 81 - 92.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
S. A. Pangas and A. Rajkovic
Transcriptional regulation of early oogenesis: in search of masters
Hum. Reprod. Update, January 1, 2006; 12(1): 65 - 76.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Z. T. Ruiz-Cortes, S. Kimmins, L. Monaco, K. H. Burns, P. Sassone-Corsi, and B. D. Murphy
Estrogen Mediates Phosphorylation of Histone H3 in Ovarian Follicle and Mammary Epithelial Tumor Cells via the Mitotic Kinase, Aurora B
Mol. Endocrinol., December 1, 2005; 19(12): 2991 - 3000.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
H. H-C Yao and B. Capel
Temperature, Genes, and Sex: a Comparative View of Sex Determination in Trachemys scripta and Mus musculus
J. Biochem., July 1, 2005; 138(1): 5 - 12.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
D. Soderlund, P. Canto, S. Carranza-Lira, and J.P. Mendez
No evidence of mutations in the P450 aromatase gene in patients with polycystic ovary syndrome
Hum. Reprod., April 1, 2005; 20(4): 965 - 969.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. L. Britt, P. K. Saunders, S. J. McPherson, M. L. Misso, E. R. Simpson, and J. K. Findlay
Estrogen Actions on Follicle Formation and Early Follicle Development
Biol Reprod, November 1, 2004; 71(5): 1712 - 1723.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
D. Tomic, K. P. Miller, H. A. Kenny, T. K. Woodruff, P. Hoyer, and J. A. Flaws
Ovarian Follicle Development Requires Smad3
Mol. Endocrinol., September 1, 2004; 18(9): 2224 - 2240.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. A. Head, V. R. Obeyesekere, M. E. Jones, E. R. Simpson, and Z. S. Krozowski
Aromatase-Deficient (ArKO) Mice Have Reduced Blood Pressure and Baroreflex Sensitivity
Endocrinology, September 1, 2004; 145(9): 4286 - 4291.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. L. Britt, P. G. Stanton, M. Misso, E. R. Simpson, and J. K. Findlay
The Effects of Estrogen on the Expression of Genes Underlying the Differentiation of Somatic Cells in the Murine Gonad
Endocrinology, August 1, 2004; 145(8): 3950 - 3960.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
P. Jeyasuria, Y. Ikeda, S. P. Jamin, L. Zhao, D. G. de Rooij, A. P. N. Themmen, R. R. Behringer, and K. L. Parker
Cell-Specific Knockout of Steroidogenic Factor 1 Reveals Its Essential Roles in Gonadal Function
Mol. Endocrinol., July 1, 2004; 18(7): 1610 - 1619.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
M Myers, K L Britt, N G M Wreford, F J P Ebling, and J B Kerr
Methods for quantifying follicular numbers within the mouse ovary
Reproduction, May 1, 2004; 127(5): 569 - 580.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. Huynh, G. Jones, G. Thouas, K. L. Britt, E. R. Simpson, and M. E.E. Jones
Estrogen Is Not Directly Required for Oocyte Developmental Competence
Biol Reprod, May 1, 2004; 70(5): 1263 - 1269.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Toda, Y. Okada, M. Zubair, K.-i. Morohashi, T. Saibara, and T. Okada
Aromatase-Knockout Mouse Carrying an Estrogen-Inducible Enhanced Green Fluorescent Protein Gene Facilitates Detection of Estrogen Actions in Vivo
Endocrinology, April 1, 2004; 145(4): 1880 - 1888.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Belgorosky, C. Pepe, R. Marino, G. Guercio, N. Saraco, E. Vaiani, and M. A. Rivarola
Hypothalamic-Pituitary-Ovarian Axis during Infancy, Early and Late Prepuberty in an Aromatase-Deficient Girl Who Is a Compound Heterocygote for Two New Point Mutations of the CYP19 Gene
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5127 - 5131.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
K. H. Burns, J. E. Agno, P. Sicinski, and M. M. Matzuk
Cyclin D2 and p27 Are Tissue-Specific Regulators of Tumorigenesis in Inhibin {alpha} Knockout Mice
Mol. Endocrinol., October 1, 2003; 17(10): 2053 - 2069.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. F. Couse, M. M. Yates, V. R. Walker, and K. S. Korach
Characterization of the Hypothalamic-Pituitary-Gonadal Axis in Estrogen Receptor (ER) Null Mice Reveals Hypergonadism and Endocrine Sex Reversal in Females Lacking ER{alpha} But Not ER{beta}
Mol. Endocrinol., June 1, 2003; 17(6): 1039 - 1053.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. Toda, T. Okada, C. Miyaura, and T. Saibara
Fenofibrate, a ligand for PPAR{alpha}, inhibits aromatase cytochrome P450 expression in the ovary of mouse
J. Lipid Res., February 1, 2003; 44(2): 265 - 270.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
K. L. BRITT, J. KERR, L. O'DONNELL, M. E. E. JONES, A. E. DRUMMOND, S. R. DAVIS, E. R. SIMPSON, and J. K. FINDLAY
Estrogen regulates development of the somatic cell phenotype in the eutherian ovary
FASEB J, September 1, 2002; 16(11): 1389 - 1397.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. H. Burns and M. M. Matzuk
Minireview: Genetic Models for the Study of Gonadotropin Actions
Endocrinology, August 1, 2002; 143(8): 2823 - 2835.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
N. Danilovich and M. R. Sairam
Haploinsufficiency of the Follicle-Stimulating Hormone Receptor Accelerates Oocyte Loss Inducing Early Reproductive Senescence and Biological Aging in Mice
Biol Reprod, August 1, 2002; 67(2): 361 - 369.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
N. Danilovich, D. Javeshghani, W. Xing, and M. R. Sairam
Endocrine Alterations and Signaling Changes Associated with Declining Ovarian Function and Advanced Biological Aging in Follicle-Stimulating Hormone Receptor Haploinsufficient Mice
Biol Reprod, August 1, 2002; 67(2): 370 - 378.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Z. Fang, S. Yang, B. Gurates, M. Tamura, E. Simpson, D. Evans, and S. E. Bulun
Genetic or Enzymatic Disruption of Aromatase Inhibits the Growth of Ectopic Uterine Tissue
J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3460 - 3466.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
G. Cheng, Z. Weihua, S. Makinen, S. Makela, S. Saji, M. Warner, J.-A. Gustafsson, and O. Hovatta
A Role for the Androgen Receptor in Follicular Atresia of Estrogen Receptor Beta Knockout Mouse Ovary
Biol Reprod, January 1, 2002; 66(1): 77 - 84.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
L. D. Quirke, J. L. Juengel, D. J. Tisdall, S. Lun, D. A. Heath, and K. P. McNatty
Ontogeny of Steroidogenesis in the Fetal Sheep Gonad
Biol Reprod, July 1, 2001; 65(1): 216 - 228.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. F. Palter, A. B. Tavares, A. Hourvitz, J. D. Veldhuis, and E. Y. Adashi
Are Estrogens of Import to Primate/Human Ovarian Folliculogenesis?
Endocr. Rev., June 1, 2001; 22(3): 389 - 424.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Britt, K. L.
Right arrow Articles by Findlay, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Britt, K. L.
Right arrow Articles by Findlay, J. K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals